Aymeric Le Chatelier - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
    • Media Statements
    • Media Library
  • Investors  arrow down
    < Back
    • Investors
    • Financial Results
    • Corporate News
    • Financial Calendar

    • Investor Events
    • Reports and Accounts
    • Regulated Information
    • Combined Shareholders’ Meeting 2024 (pre announcement page launch)

      Featured Image
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Slovakia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Stories
  1. Home
  2. Company
  3. Leadership Team
  4. leadership

Aymeric Le Chatelier

Back
Aymeric Le Chatelier

Aymeric Le Chatelier

  • Executive Vice President,
  • Group Chief Financial Officer
  • Follow in LinkedIn

Aymeric Le Chatelier was appointed Executive Vice President, Group Chief Financial Officer in November 2014.

Aymeric, a graduate from HEC Business School, started his career at Arthur Andersen. He successively executed several roles in finance in France and the United States at Veolia. He then joined Arjowiggins, a leading manufacturer of creative and technical paper, as Group Chief Financial Officer. He was subsequently appointed Financial Director of Enedis and member of the Management Board.

Aymeric served as interim Chief Executive Officer of the Group from January 1, 2020 until David Loew was appointed Chief Executive Officer in July 2020.

IPN price

€101.90

 €-1.10 (-1.07%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Responsibility
  • Patients
  • Stories
  • Annual Report
  • Contact us

Global
LinkedIn Twitter Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2023

You are now leaving the Ipsen group website.To continue, please click on Continue?

Continue